BYDENAF

Pharmaceutical preparations for treating genetic disorders; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating Huntington's disease and related disorders; pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; and pharmaceutical preparations for treating NAFLD and NASH disease and related disorders